IL-1 receptor antagonist levels.

IL-1Ra levels were equivalent at the onset of the infusion, but in the IL-1Ra group, serum levels rapidly rose 1000-fold over control. Drug level was sustained at this high level until the discontinuation of the infusion, when it returned to baseline.